| Completed | Benefit and Tolerability of IQP-LU-104 in Weight Loss Overweight, Obesity | N/A | 2019-03-05 |
| Withdrawn | Vasoactive Effects of IQP-AS-118 in Healthy Individuals Blood Flow, Cardiovascular Disease | N/A | 2018-03-01 |
| Completed | Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity Dentin Sensitivity | N/A | 2017-08-25 |
| Completed | Efficacy and Safety of Litramine in 1 Year Weight Loss Study Obesity; Excess Calories, Overweight and Obesity, Weight Loss | N/A | 2017-08-14 |
| Completed | Benefit and Tolerability of IQP-AE-103 in Weight Loss Overweight, Obesity | N/A | 2017-05-01 |
| Completed | Benefit of IQP-AO-101 for Sleep Insomnia, Nonorganic | N/A | 2017-04-25 |
| Completed | Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol Blood Pressure, Low Density Lipoprotein Cholesterol Level | N/A | 2017-03-17 |
| Withdrawn | Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness Fatigue | N/A | 2016-11-01 |
| Completed | Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects Hyperglycemia, Postprandial | N/A | 2016-08-01 |
| Completed | Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others Upper Respiratory Tract Symptoms | N/A | 2016-07-10 |
| Completed | Efficacy and Safety of Glucosanol™ in Body Weight Reduction Overweight and Obesity | N/A | 2016-05-01 |
| Completed | Efficacy and Safety of IQP-AK-102 in Reducing Appetite Appetite Regulation, Appetite Suppression, Energy Intake | N/A | 2016-05-01 |
| Completed | Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects Prediabetes, Hyperglycemia | Phase 3 | 2014-06-01 |
| Completed | Safety and Efficacy of IQP-AK-102 in Reducing Appetite Weight Loss, Appetite Modulation (Focus of Study) | Phase 3 | 2014-01-01 |
| Completed | Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea Diarrhoea | N/A | 2013-10-01 |
| Terminated | Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections Common Cold, Upper Respiratory Tract Infections | Phase 3 | 2013-10-01 |
| Completed | Safety and Efficacy of IQP- AK-102 in Reducing Body Weight Weight Loss | Phase 3 | 2013-07-01 |
| Completed | IQP-PO-101 for the Regulation of Bowel Movement Frequency Constipation, Irregular Bowel Movement Frequency | Phase 3 | 2013-03-01 |
| Completed | IQP-CL-101 in IBS Management Irritable Bowel Syndrome | Phase 3 | 2013-01-01 |
| Completed | Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn Postprandial Heartburn | Phase 4 | 2012-10-01 |
| Completed | Efficacy and Safety of IQP-VV-102 in Weight Management Obesity, Overweight | Phase 3 | 2012-10-01 |
| Completed | Litramine for Weight Loss Weight Loss | N/A | 2012-09-01 |
| Completed | Effect of Litramine on Fat Excretion Healthy Subjects | Phase 4 | 2012-05-01 |
| Completed | Litramine in Weight Maintenance Weight Maintenance, Overweight, Obese | Phase 4 | 2012-01-01 |
| Completed | Nasya in Allergic Rhinitis Allergic Rhinitis | Phase 3 | 2012-01-01 |
| Completed | Efficacy and Safety of Glucosanol in Maintaining Body Weight Overweight, Obesity | Phase 4 | 2011-09-01 |
| Completed | Efficacy and Safety of Zenoctil in Reducing Body Weight Overweight | Phase 3 | 2011-07-01 |
| Completed | Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects Overweight and Obesity | Phase 4 | 2011-05-01 |
| Completed | Safety and Efficacy of Litramine in Overweight and Obese Subjects Overweight, Obesity, Weight Loss | Phase 3 | 2010-07-01 |